4,4-dimethyl-1-phenyl-pentan-1-ol;α-(3,3-dimethyl-butyl)-benzenemethanol;(β-tert.-Butylethyl)phenylmethanol;1-Phenyl-4,4-dimethyl-1-pentanol;US11618753, Example 161;4,4-dimethyl-1-phenylpentan-1-ol
Alkylation of Aldehydes with Trialkylboranes in Water
作者:Koji Hirano、Hideki Yorimitsu、Koichiro Oshima
DOI:10.1002/adsc.200606136
日期:2006.8
Water enables the alkylation of aldehydes with trialkylboranes under nickel catalysis without the addition of a base. Trialkylboranes prepared from borane-dimethyl sulfide and terminal olefins via hydroboration as well as commercially available trialkylboranes could be employed for the reaction. The reaction would proceed via η2-coordinated nickel complexes with aldehydes as the key intermediates.
Efficient Iron-Catalyzed Direct β-Alkylation of Secondary Alcohols with Primary Alcohols
作者:Jian Yang、Xin Liu、Da-Li Meng、Hong-Yan Chen、Zhi-Hui Zong、Ting-Ting Feng、Kai Sun
DOI:10.1002/adsc.201000907
日期:2012.2
β-alkylation of secondary alcohols with primaryalcohols is described. In the presence of the commerciallyavailable iron catalyst (ferrocenecarboxaldehyde, 1b) and a catalytic amount of base, the reactions give β-alkylated higher alcohols in high yields in the absence of any sacrificial agents (hydrogen acceptors or hydrogen donors) and nitrogen or phosphorus ligands. For the firsttime, iron is employed
The disclosure relates to compounds of formula I which are useful as kinase modulators including RIPK 1 modulation. The disclosure also provides methods of making and using the compounds for example in treatments related to necrosis or inflammation as well as other indications.
INDAZOLE CARBOXAMIDES AS KINASE INHIBITORS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20210309633A1
公开(公告)日:2021-10-07
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.